Pharmacodynamic changes in tumor and immune cells drive iberdomide’s clinical mechanisms of activity in relapsed and refractory multiple myeloma
Article in Cell Reports Medicine (May 2024)
The most recent citing publications are shown below. View all 477 publications that cite this research output on Dimensions.
Article in Cell Reports Medicine (May 2024)
Article in International Journal of Molecular Sciences (May 2024)
Article in Blood Cancer Journal (April 2024)